Highest-materiality recent filing
Avery Dennison Q1 adj EPS $2.47, up 7.4%; guides Q2 adj EPS $2.43-$2.53
Reported EPS $2.18; adjusted EPS $2.47 (+7.4% YoY). Net sales $2.3B, +7.0%.
Avery Dennison reports FY25 adj EPS $9.53 (+1%), Q4 adj EPS $2.45 (+3%), sales $8.9B
FY25 reported EPS $8.79; adjusted EPS $9.53, up 1% YoY.
Avery Dennison Q3 adjusted EPS $2.37 (+2%), net sales $2.2B (+1.5%)
Reported EPS $2.13; adjusted EPS $2.37, up 2% YoY.
Avery Dennison Q2 2025 adj. EPS $2.42, flat YoY; Q3 guidance adj. EPS $2.24-$2.40
Reported EPS $2.41; adjusted EPS $2.42, flat versus prior year, up 5% sequentially.
Board authorized up to $750M in additional share repurchases (excluding fees).
Reported EPS $2.09; adjusted EPS $2.30 (up 0.4% YoY, ~4% ex currency).
Avery Dennison Q4 adj EPS $2.38, FY adj EPS $9.43 (up 19%); guides FY25 adj EPS $9.80-10.20
Q4 2024 net sales $2.2B (+3.6%); reported EPS $2.16, adjusted EPS $2.38 (+10%).
Avery Dennison CFO Gregory Lovins takes medical leave; Danny Allouche named Interim CFO
CFO Gregory Lovins began medical leave Nov 14, 2024; ceased as principal financial officer.
3Q24 reported EPS $2.25 (+32% YoY); adjusted EPS $2.33 (+9% YoY).
Avery Dennison Q2 adjusted EPS $2.42 (+26%); raises FY adjusted EPS guidance to $9.30-9.50
Reported EPS $2.18 (+76%), adjusted EPS $2.42 (+26%) on net sales $2.2B (+7% organic).
Avery Dennison appoints former WestRock CFO Ward Dickson to board, as Audit Chair
Ward Dickson appointed to Board effective June 1, 2024; named Chair of Audit Committee and member of Finance Committee.
Avery Dennison Q1 EPS $2.13 (+43% YoY); adj. EPS $2.29 (+35%); raises FY guidance
Reported EPS $2.13, up 43% YoY; adjusted EPS $2.29, up 35% YoY.
Danny G. Allouche will cease serving as the Company’s Interim Chief Financial Officer and principal financial officer on March 31, 2025; he will continue serving as the Company’s Senior Vice President and Chief Strategy and Corporate Development Officer.
Effective April 1, 2025, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the “Company”), will resume serving as the Company’s principal financial officer following a previously disclosed medical leave of absence that began on November 14, 2024.
On December 27, 2024, Martha N. Sullivan, a 12-year member of the Board of Directors (the “Board”) of Avery Dennison Corporation, a Delaware corporation (the “Company”), notified the Company’s Executive Chairman, its Chief Executive Officer, the Board’s Lead Independent Director and the Board’s Governance Committee Chair of her decision to resign from the Board effective December 31, 2024 to pursue new professional opportunities.
On November 14, 2024, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the "Company"), began a medical leave of absence.
On November 14, 2024, the Company’s Board of Directors (the “Board”) elected Danny G. Allouche as the Company’s Senior Vice President and Interim Chief Financial Officer, effective November 15, 2024.
appointed Ward Dickson as a director, effective June 1, 2024.
Max materiality 0.80 · Median 0.60 · Most common event earnings